Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

TherapeuticsMD, Inc. Director's Dealing 2008

Jul 15, 2008

35134_dirs_2008-07-15_d08f2689-6bc8-4d88-845e-ee1e6dbe5b57.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CROFF ENTERPRISES INC (COFF)
CIK: 0000025743
Period of Report: 2008-06-21

Reporting Person: MANDEL RICHARD H JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-06-21 Croff Enterprises Common Stock S 5000 $1.82 Disposed 13100 Direct